• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌中 Ki67 增殖指数:多种计数方法的比较研究及图像分析和深度学习平台的验证。

Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.

机构信息

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Histopathology. 2023 Dec;83(6):981-988. doi: 10.1111/his.15048. Epub 2023 Sep 14.

DOI:10.1111/his.15048
PMID:37706239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10840805/
Abstract

AIMS

The International Medullary Thyroid Carcinoma Grading System, introduced in 2022, mandates evaluation of the Ki67 proliferation index to assign a histological grade for medullary thyroid carcinoma. However, manual counting remains a tedious and time-consuming task.

METHODS AND RESULTS

We aimed to evaluate the performance of three other counting techniques for the Ki67 index, eyeballing by a trained experienced investigator, a machine learning-based deep learning algorithm (DeepLIIF) and an image analysis software with internal thresholding compared to the gold standard manual counting in a large cohort of 260 primarily resected medullary thyroid carcinoma. The Ki67 proliferation index generated by all three methods correlate near-perfectly with the manual Ki67 index, with kappa values ranging from 0.884 to 0.979 and interclass correlation coefficients ranging from 0.969 to 0.983. Discrepant Ki67 results were only observed in cases with borderline manual Ki67 readings, ranging from 3 to 7%. Medullary thyroid carcinomas with a high Ki67 index (≥ 5%) determined using any of the four methods were associated with significantly decreased disease-specific survival and distant metastasis-free survival.

CONCLUSIONS

We herein validate a machine learning-based deep-learning platform and an image analysis software with internal thresholding to generate accurate automatic Ki67 proliferation indices in medullary thyroid carcinoma. Manual Ki67 count remains useful when facing a tumour with a borderline Ki67 proliferation index of 3-7%. In daily practice, validation of alternative evaluation methods for the Ki67 index in MTC is required prior to implementation.

摘要

目的

2022 年引入的国际髓样甲状腺癌分级系统要求评估 Ki67 增殖指数,以确定髓样甲状腺癌的组织学分级。然而,手动计数仍然是一项繁琐且耗时的任务。

方法和结果

我们旨在评估三种其他 Ki67 指数计数技术的性能,包括由经验丰富的训练有素的研究人员进行的目测、基于机器学习的深度学习算法(DeepLIIF)和具有内部阈值的图像分析软件,与手动计数相比,在 260 例主要切除的髓样甲状腺癌的大队列中评估其性能。所有三种方法生成的 Ki67 增殖指数与手动 Ki67 指数非常接近,kappa 值范围为 0.884 至 0.979,组内相关系数范围为 0.969 至 0.983。只有在手动 Ki67 读数处于边缘的情况下才会出现 Ki67 结果不一致的情况,范围为 3%至 7%。使用这四种方法中的任何一种确定的高 Ki67 指数(≥5%)的髓样甲状腺癌与疾病特异性生存率和远处无转移生存率显著降低相关。

结论

我们在此验证了一种基于机器学习的深度学习平台和一种具有内部阈值的图像分析软件,可在髓样甲状腺癌中生成准确的自动 Ki67 增殖指数。当面临 Ki67 增殖指数为 3%至 7%的边界肿瘤时,手动 Ki67 计数仍然有用。在日常实践中,在实施之前,需要对替代的 Ki67 指数评估方法在 MTC 中的验证。

相似文献

1
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.甲状腺髓样癌中 Ki67 增殖指数:多种计数方法的比较研究及图像分析和深度学习平台的验证。
Histopathology. 2023 Dec;83(6):981-988. doi: 10.1111/his.15048. Epub 2023 Sep 14.
2
Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.数字图像分析在甲状腺髓样癌分级中 Ki67 定量评估的探索:85 例初步研究
Head Neck Pathol. 2023 Sep;17(3):638-646. doi: 10.1007/s12105-023-01564-8. Epub 2023 Jun 9.
3
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.国际甲状腺髓样癌分级系统:甲状腺髓样癌的有效分级系统。
J Clin Oncol. 2022 Jan 1;40(1):96-104. doi: 10.1200/JCO.21.01329. Epub 2021 Nov 3.
4
Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.用国际甲状腺髓样癌分级系统对细针抽吸细胞学标本进行甲状腺髓样癌分级:细胞学-组织学相关性。
Cancer Cytopathol. 2024 Apr;132(4):224-232. doi: 10.1002/cncy.22778. Epub 2023 Dec 8.
5
External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.单一机构队列中三种髓样甲状腺癌分级系统的外部验证。
Endocr Pathol. 2022 Sep;33(3):359-370. doi: 10.1007/s12022-022-09719-z. Epub 2022 May 18.
6
Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.孤立性髓样甲状腺癌国际分级系统的独立验证:单中心经验。
Mod Pathol. 2023 Sep;36(9):100235. doi: 10.1016/j.modpat.2023.100235. Epub 2023 Jun 1.
7
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.基于全组织切片虚拟双重染色的乳腺癌 Ki67 增殖指数的数字图像分析:临床验证和平台间一致性。
Breast Cancer Res Treat. 2018 May;169(1):33-42. doi: 10.1007/s10549-018-4669-2. Epub 2018 Jan 18.
8
[Expression and clinical significance of Ki67 and calcitonin in medullary thyroid carcinoma].甲状腺髓样癌中Ki67和降钙素的表达及临床意义
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Dec;28(24):1921-4.
9
International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.国际髓样甲状腺癌分级系统:一家印度三级医疗中心的经验
Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1571-1579. doi: 10.1007/s00405-023-08341-x. Epub 2023 Nov 27.
10
Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.Prox1 在甲状腺髓样癌中的表达与嗜铬粒蛋白 A 和降钙素的表达以及 Ki67 增殖指数相关,但与预后无关。
Endocr Pathol. 2019 Jun;30(2):138-145. doi: 10.1007/s12022-019-9576-5.

引用本文的文献

1
Machine learning in endocrinology: current applications and future perspectives.内分泌学中的机器学习:当前应用与未来展望。
Endocrine. 2025 Aug 20. doi: 10.1007/s12020-025-04378-6.
2
AI in Histopathology Explorer for comprehensive analysis of the evolving AI landscape in histopathology.组织病理学中的人工智能探索器,用于全面分析组织病理学中不断发展的人工智能格局。
NPJ Digit Med. 2025 Mar 12;8(1):156. doi: 10.1038/s41746-025-01524-2.
3
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.曲克芦丁(Trox)在对抗间变性甲状腺癌(ATC)进展中的保护作用。
Biomedicines. 2024 Aug 5;12(8):1755. doi: 10.3390/biomedicines12081755.
4
β-asarone induces viability and angiogenesis and suppresses apoptosis of human vascular endothelial cells after ischemic stroke by upregulating vascular endothelial growth factor A.β-细辛脑通过上调血管内皮生长因子 A 诱导缺血性脑卒中后血管内皮细胞的活力和血管生成,并抑制其凋亡。
PeerJ. 2024 Jun 27;12:e17534. doi: 10.7717/peerj.17534. eCollection 2024.

本文引用的文献

1
Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.数字图像分析在甲状腺髓样癌分级中 Ki67 定量评估的探索:85 例初步研究
Head Neck Pathol. 2023 Sep;17(3):638-646. doi: 10.1007/s12105-023-01564-8. Epub 2023 Jun 9.
2
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.Ki67 增殖指数在神经内分泌和内分泌肿瘤中的诊断、预后和预测作用:过去、现在和未来。
Endocr Pathol. 2023 Mar;34(1):79-97. doi: 10.1007/s12022-023-09755-3. Epub 2023 Feb 17.
3
Unsupervised domain adaptive tumor region recognition for Ki67 automated assisted quantification.用于Ki67自动辅助定量的无监督域自适应肿瘤区域识别
Int J Comput Assist Radiol Surg. 2023 Apr;18(4):629-640. doi: 10.1007/s11548-022-02781-2. Epub 2022 Nov 13.
4
DeepLIIF: An Online Platform for Quantification of Clinical Pathology Slides.DeepLIIF:一个用于临床病理切片定量分析的在线平台。
Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit. 2022;2022:21399-21405.
5
Deep Learning-Inferred Multiplex ImmunoFluorescence for Immunohistochemical Image Quantification.用于免疫组织化学图像定量的深度学习推断多重免疫荧光
Nat Mach Intell. 2022 Apr;4(4):401-412. doi: 10.1038/s42256-022-00471-x. Epub 2022 Apr 7.
6
External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.单一机构队列中三种髓样甲状腺癌分级系统的外部验证。
Endocr Pathol. 2022 Sep;33(3):359-370. doi: 10.1007/s12022-022-09719-z. Epub 2022 May 18.
7
Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.甲状腺髓样癌分级:一项观察者间可重复性研究。
Endocr Pathol. 2022 Sep;33(3):371-377. doi: 10.1007/s12022-022-09718-0. Epub 2022 May 13.
8
Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ).利用深度学习评估导管原位癌(DCIS)中的Ki-67增殖指数。
Sci Rep. 2022 Feb 24;12(1):3166. doi: 10.1038/s41598-022-06555-3.
9
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.国际甲状腺髓样癌分级系统:甲状腺髓样癌的有效分级系统。
J Clin Oncol. 2022 Jan 1;40(1):96-104. doi: 10.1200/JCO.21.01329. Epub 2021 Nov 3.
10
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.《散发性与家族性髓样甲状腺癌的基因组学和表观基因组学研究》
Endocr Pathol. 2021 Mar;32(1):35-43. doi: 10.1007/s12022-021-09664-3. Epub 2021 Jan 25.